Caprock Group LLC bought a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 12,037 shares of the conglomerate’s stock, valued at approximately $2,478,000.
Other large investors also recently added to or reduced their stakes in the company. Tyche Wealth Partners LLC bought a new position in shares of Danaher during the 3rd quarter valued at approximately $462,000. Ceredex Value Advisors LLC lifted its position in Danaher by 1.6% during the second quarter. Ceredex Value Advisors LLC now owns 249,377 shares of the conglomerate’s stock valued at $49,262,000 after purchasing an additional 3,862 shares during the last quarter. Weitz Investment Management Inc. grew its stake in shares of Danaher by 6.1% in the 2nd quarter. Weitz Investment Management Inc. now owns 526,950 shares of the conglomerate’s stock worth $104,094,000 after buying an additional 30,300 shares in the last quarter. Lockheed Martin Investment Management Co. increased its holdings in shares of Danaher by 49.4% in the 3rd quarter. Lockheed Martin Investment Management Co. now owns 25,340 shares of the conglomerate’s stock worth $5,024,000 after buying an additional 8,380 shares during the last quarter. Finally, Nvwm LLC increased its holdings in shares of Danaher by 20.4% in the 2nd quarter. Nvwm LLC now owns 7,093 shares of the conglomerate’s stock worth $1,401,000 after buying an additional 1,204 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.
Danaher Trading Down 2.3%
DHR stock opened at $214.92 on Friday. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $242.80. The firm’s 50-day moving average is $228.91 and its 200 day moving average is $215.40. The company has a market capitalization of $151.81 billion, a PE ratio of 42.64, a P/E/G ratio of 2.97 and a beta of 0.91. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, December 26th were issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s dividend payout ratio is currently 25.40%.
Wall Street Analyst Weigh In
Several research analysts recently commented on DHR shares. Guggenheim lifted their price target on Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a research report on Friday, January 2nd. TD Cowen reiterated a “buy” rating on shares of Danaher in a report on Wednesday, January 7th. KeyCorp restated an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. Leerink Partners lifted their price objective on shares of Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Finally, Evercore reiterated an “outperform” rating and set a $254.00 price objective on shares of Danaher in a research report on Wednesday, January 28th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average price target of $253.86.
Get Our Latest Stock Report on Danaher
Insider Activity
In other news, Director Teri List sold 3,298 shares of the firm’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the transaction, the director owned 20,762 shares in the company, valued at approximately $4,702,593. This trade represents a 13.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 11.10% of the company’s stock.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
